ODONATE THERAPEUTICS INC's ticker is ODT and the CUSIP is 676079106. A total of 95 filers reported holding ODONATE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.75 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $82,000 | -53.7% | 60,901 | 0.0% | 0.00% | – |
| Q3 2021 | $177,000 | -75.0% | 60,901 | -70.0% | 0.00% | – |
| Q2 2021 | $709,000 | +189.4% | 202,963 | +183.5% | 0.00% | – |
| Q1 2021 | $245,000 | -82.7% | 71,582 | -2.9% | 0.00% | -100.0% |
| Q4 2020 | $1,416,000 | +50.6% | 73,712 | +5.3% | 0.00% | 0.0% |
| Q3 2020 | $940,000 | +234.5% | 70,012 | +954.6% | 0.00% | – |
| Q2 2020 | $281,000 | +198.9% | 6,639 | +94.9% | 0.00% | – |
| Q1 2020 | $94,000 | -70.7% | 3,407 | -65.8% | 0.00% | – |
| Q4 2019 | $321,000 | +58.1% | 9,952 | +27.1% | 0.00% | – |
| Q3 2019 | $203,000 | -7.3% | 7,833 | +30.5% | 0.00% | – |
| Q2 2019 | $219,000 | +17.7% | 6,004 | -29.4% | 0.00% | – |
| Q1 2019 | $186,000 | +51.2% | 8,505 | -3.3% | 0.00% | – |
| Q4 2018 | $123,000 | -78.0% | 8,795 | -69.5% | 0.00% | – |
| Q3 2018 | $558,000 | +5.3% | 28,849 | +19.9% | 0.00% | – |
| Q2 2018 | $530,000 | +188.0% | 24,058 | +175.4% | 0.00% | – |
| Q1 2018 | $184,000 | – | 8,736 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 15,514,566 | $297,880,000 | 45.48% |
| Boxer Capital, LLC | 5,607,086 | $107,656,000 | 3.46% |
| Samsara BioCapital, LLC | 815,421 | $15,656,000 | 1.57% |
| GSA CAPITAL PARTNERS LLP | 148,148 | $2,844,000 | 0.46% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,211,728 | $23,265,000 | 0.38% |
| RTW INVESTMENTS, LP | 1,000,139 | $19,203,000 | 0.32% |
| Sio Capital Management, LLC | 75,500 | $1,450,000 | 0.30% |
| AlphaCentric Advisors LLC | 29,594 | $568,000 | 0.24% |
| Birchview Capital, LP | 20,000 | $384,000 | 0.22% |
| Aristides Capital LLC | 33,226 | $638,000 | 0.22% |